According to Burning Rock Biotech's latest financial reports the company's current EPS (TTM) is -$1.06. In 2022 the company made an earnings per share (EPS) of -$1.39 a decrease over its 2021 EPS that were of -$1.18.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$1.06 | -23.6% |
2022 | -$1.39 | 17.02% |
2021 | -$1.18 | 31.91% |
2020 | -$0.90 | 61.71% |
2019 | -$0.56 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
LabCorp LH | $7.52 | -810.16% | ๐บ๐ธ USA |
OpGen
OPGN | -$12.05 | 1,037.95% | ๐บ๐ธ USA |
NeoGenomics
NEO | -$0.92 | -13.12% | ๐บ๐ธ USA |